Involvement of IL-6 in the Pathogenesis of Inflammatory Bowel Disease and Colon Cancer
- 1 January 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Reviews in Allergy & Immunology
- Vol. 28 (3), 187-196
- https://doi.org/10.1385/criai:28:3:187
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibitionAlimentary Pharmacology & Therapeutics, 2003
- Crohn's diseaseThe Lancet, 2002
- Bax is downregulated in inflamed colonic mucosa of ulcerative colitisGut, 2000
- Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6Gut, 2000
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependentDigestive Diseases and Sciences, 1995
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.Gut, 1994
- Mucosal Interleukin-6 Secretion in Ulcerative Colitis: Effects of Anti-Inflammatory Drugs and T-Cell StimulationScandinavian Journal of Gastroenterology, 1994
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.Gut, 1992